NCT04449198View on ClinicalTrials.gov

Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

January 1, 2027

Study Completion Date

July 1, 2027

Conditions
Type 1 Diabetes
Interventions
DRUG

Resveratrol

500 mg of oral trans-resveratrol twice daily (in the morning and evening) for 12-weeks

OTHER

Placebo

placebo for 12 weeks

Trial Locations (1)

30912

RECRUITING

Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology, Augusta

All Listed Sponsors
lead

Augusta University

OTHER